Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 2, 1999, Pages 177-182

  Franklin, Scott ^a   Pho, Thuy ^a   Abreo, Fleurette W ^c   Nassar, Raja ^b   De Benedetti, Arrigo ^c   Stucker, Fred J ^a   Nathan, Cherie Ann O ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b Louisiana Tech University   (United States)

^c LSU Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MALE; PROTO ONCOGENE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

EID: 0033016896     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.2.177     Document Type: Article

References (25)

1. Sonenberg N. mRNA 5′ cap-binding protein elF4E and control of cell growth. In: Translational Control. Plainville, NY: Cold Springs Harbor Laboratory Press; 1996: 245-269.
2. Shantz L, Pegg A. Overproduction of omithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res. 1994;54:2313-2316.
3. Lazaris-Karatzas A, Montine K, Sonenberg N. Malignant transformation byaeukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature. 1990;345: 544-546.
4. De Benedetti A, Rhoads RE. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci U S A. 1990;87:8212-8216.
5. Kevil C, Carter P, Hu B, De Benedetti A. Translational enhancement of FGF-2 by elF4E factors and alternate utilization of CUG and AUG codons for translational initiation. Oncogene. 1995;11:2339-2348.
6. Koromilas A, Lararis-Karatzas A, Sonenberg N. mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor elF4E. EMBO. 1992;11:4153-4158.
7. Kevil C, De Benedetti A, Payne D, Coe L, Laroux S, Alexander J. Translation regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer. 1996;65:785-790.
8. Nathan CO, Carter P, Liu L, et al. Elevated expression of elF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene. 1997;15:1087-1094.
9. Nathan CO, Liu L, Li B, Abreo F, Nandy I, De Benedetti. Detection of the proto-oncogene elF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene. 1997;15:579-584.
10. Gilbert H, Kagan R. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol. 1974;6:357-380.
11. Looser K, Shah J, Strong E. The significance of "positive" margins in surgically resectedepidermoidcarcinomas. Head Neck. 1978;1:107-111.
12. Caminero M, Nunez F, Suarez C, Ablanedo P, Riera J, Dominguez F. Detection of p53 protein in oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1996; 122:769-772.
13. Michalides R, van Veelen N, Kristel P, et al. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1997;123:497-502.
14. Kerekatte V, Smiley K, Hu B, et al. The proto-oncogene/translation factor elF4E: a survey of its expression in breast carcinomas. Int J Cancer. 1995;64:27-31.
15. Pavelic Z, Pavelic K, Carter C, Pavelic L. Heterogenity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast. J Cancer Res Clin Oncol. 1992;118:16-22.
16. Nees M, Homann N, Discher H, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res. 1993;53:4189-4196.
17. Dolcetti R, Doglioni C, Maestro R, et al. p53 over-expression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer. 1990;52:178-182.
18. Somers KD, Merrick M, Lopez M, et al. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992;52:5997-6000.
19. Maestro R, Dolcetti D, Gasparotto C, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene. 1992;7:1159-1166.
20. Brennan J, Mao L, Hruban R, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Engl J Med. 1995; 332:429-435.
21. Ball V, Right P, Tejada E, Radpour S. p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx. Ear Nose Throat J. 1997;76:818-823.
22. Field J, Spandidos D, Malliri A, et al. Elevated p53 expression with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer. 1991;64:573-577.
23. Jesse R, Sugarbaker E. Squamous cell carcinoma of the oropharynx: why we fail. Am J Surg. 1976;132:435-438.
24. Kowalski L, Margrin J, Waksman G, et al. Supraomohyoid neck dissection in the treatment of head and neck tumors: survival results in 212 cases. Arch Otolaryngol Head Neck Surg. 1993;119:958-963.
25. Davidson T, Nahum A, Astarita R. Microscopic controlled excisions for epidermoid carcinoma of the head and neck. Otolaryngol Head Neck Surg. 1981;89: 244-251.